Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Lacosamide Patent Expiration

Lacosamide is Used for treating partial-onset seizures in patients with epilepsy aged 17 years and older, either as adjunctive therapy or when oral treatment is temporarily not feasible. It was first introduced by Ucb Inc in its drug Vimpat on Oct 28, 2008. Another drug containing Lacosamide is Motpoly Xr. 32 different companies have introduced drugs containing Lacosamide.


Lacosamide Patents

Given below is the list of patents protecting Lacosamide, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Motpoly Xr US11337943 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Motpoly Xr US11883374 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Motpoly Xr US12042474 Lacosamide pharmaceutical composition and dosage form thereof Jun 05, 2040 Aucta
Vimpat USRE38551 Anticonvulsant enantiomeric amino acid derivatives Mar 17, 2022

(Expired)

 Ucb Inc
Vimpat US5654301 Amino acid derivative anticonvulsant Aug 05, 2014

(Expired)

 Ucb Inc



Lacosamide's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Lacosamide Generic API Manufacturers

Several generic applications have been filed for Lacosamide. The first generic version for Lacosamide was by Mylan Pharmaceuticals Inc and was approved on Apr 28, 2016. And the latest generic version is by Somerset Therapeutics Llc and was approved on Oct 9, 2024.

Given below is the list of companies who have filed for Lacosamide generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Discontinued ORAL N/A Jul 12, 2022
150MG

tablet Discontinued ORAL N/A Jul 12, 2022
100MG

tablet Discontinued ORAL N/A Jul 12, 2022
50MG

tablet Discontinued ORAL N/A Jul 12, 2022





2. ACTAVIS LABS FL INC

Actavis Laboratories Fl Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Discontinued ORAL N/A Jan 5, 2023
50MG

tablet Discontinued ORAL N/A Jan 5, 2023
150MG

tablet Discontinued ORAL N/A Jan 5, 2023
200MG

tablet Discontinued ORAL N/A Jan 5, 2023





3. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022


Manufacturing Plant Locations
New

Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.

Country City Firm Name
India
Panelav Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd
Panchmahal Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Limited
Vadodara Alembic Pharmaceuticals Ltd (API Division, Karakhadi)
Vadodara Alembic Pharmaceuticals, Ltd
Panchmahal Alembic Pharmaceuticals Limited (Units I and II)





4. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 31, 2022
200MG

tablet Prescription ORAL AB Mar 31, 2022
150MG

tablet Prescription ORAL AB Mar 31, 2022
100MG

tablet Prescription ORAL AB Mar 31, 2022
10MG/ML

solution Prescription ORAL AA May 19, 2022





5. AMNEAL PHARMS

Amneal Pharmaceuticals has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Discontinued ORAL N/A Mar 17, 2022
150MG

tablet Discontinued ORAL N/A Mar 17, 2022
200MG

tablet Discontinued ORAL N/A Mar 17, 2022
50MG

tablet Discontinued ORAL N/A Mar 17, 2022
10MG/ML

solution Discontinued ORAL N/A Mar 27, 2024





6. APOTEX

Apotex Inc has filed for 6 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Apotex.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Discontinued ORAL N/A Sep 23, 2022
100MG

tablet Discontinued ORAL N/A Sep 23, 2022
50MG

tablet Discontinued ORAL N/A Sep 23, 2022
200MG

tablet Discontinued ORAL N/A Sep 23, 2022
10MG/ML

solution Prescription ORAL AA Sep 26, 2022
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Nov 13, 2023


Manufacturing Plant Locations
New

Apotex's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Apotex as present at those locations.

Country City Firm Name
United States
Weston Apotex Corp.
Canada
Brantford Apotex Pharmachem Inc.
Winnipeg Apotex Fermentation Inc.
Etobicoke Apotex, Inc.
North York Apotex Inc.
Richmond Hill Apotex Inc.
Toronto Apotex Inc.
India
Bangalore Apotex Research Private Limited - Bioequivalence Centre
Bengaluru Apotex Research Private Limited
Bangalore Apotex Pharmachem India Pvt Ltd.





7. ASPIRO

Aspiro Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Aspiro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Sep 14, 2022


Manufacturing Plant Locations
New

Aspiro's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aspiro as present at those locations.

Country City Firm Name
India
Siddipet (Dist) Aspiro Pharma Limited





8. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Jan 5, 2023
100MG

tablet Prescription ORAL AB Jan 5, 2023
150MG

tablet Prescription ORAL AB Jan 5, 2023
200MG

tablet Prescription ORAL AB Jan 5, 2023
10MG/ML

solution Prescription ORAL AA Jan 24, 2024


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





9. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA May 15, 2024





10. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Mar 25, 2024





11. FRESENIUS KABI USA

Fresenius Kabi Usa Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Fresenius Kabi Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP May 3, 2022


Manufacturing Plant Locations
New

Fresenius Kabi Usa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Fresenius Kabi Usa as present at those locations.

Country City Firm Name
United States
Melrose Park Fresenius Kabi USA, LLC
Wilson Fresenius Kabi USA, LLC
Skokie Fresenius Kabi USA LLC
Grand Island Fresenius Kabi USA, LLC
North Andover Fresenius Kabi USA, LLC
Bensenville Fresenius Kabi USA LLC (FK USA)
Melrose Park Fresenius Kabi USA LLC
Lake Zurich Fresenius Kabi USA, LLC





12. GLAND PHARMA LTD

Gland Pharma Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Sep 19, 2022





13. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022





14. HAINAN POLY

Hainan Poly Pharm Co Ltd has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hainan Poly.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Feb 13, 2024


Manufacturing Plant Locations
New

Hainan Poly's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Hainan Poly as present at those locations.

Country City Firm Name
China
Haikou Hainan Poly Pharm. Co., Ltd.





15. HETERO LABS LTD III

Hetero Labs Ltd Unit Iii has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd Iii.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA May 31, 2022





16. HETERO LABS LTD V

Hetero Labs Ltd Unit V has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Hetero Labs Ltd V.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022





17. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Apr 5, 2024


Manufacturing Plant Locations
New

Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.

Country City Firm Name
United States
Eatontown Hikma Pharmaceuticals USA, Inc.
Cherry Hill Hikma Pharmaceuticals USA Inc.
Dayton Hikma Injectables USA Inc
Carlsbad Hikma Cali Inc. DBA Leucadia Pharmaceuticals
Portugal
Terrugem Snt Hikma Farmaceutica, (Portugal) S.A.
Jordan
Amman Hikma Pharmaceuticals LLC





18. INDOCO

Indoco Remedies Ltd has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Indoco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
50MG

tablet Prescription ORAL AB Mar 17, 2022
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Apr 7, 2022


Manufacturing Plant Locations
New

Indoco's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Indoco as present at those locations.

Country City Firm Name
India
Verna Indoco Remedies Limited
Navi Mumbai Indoco Remedies Limited
Taluka Khalapur, District Raigad Indoco Remedies Limited
Verna Indoco Remedies Limited (Plant I)





19. KANCHAN HLTHCARE

Kanchan Healthcare Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Kanchan Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Apr 2, 2024
50MG

tablet Prescription ORAL AB Apr 2, 2024
100MG

tablet Prescription ORAL AB Apr 2, 2024
150MG

tablet Prescription ORAL AB Apr 2, 2024





20. LEADING PHARMA

Leading Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Leading Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA Feb 6, 2023


Manufacturing Plant Locations
New

Leading Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Leading Pharma as present at those locations.

Country City Firm Name
United States
Fairfield Leading Pharma, LLC





21. MACLEODS PHARMS LTD

Macleods Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB May 24, 2024
100MG

tablet Prescription ORAL AB May 24, 2024
150MG

tablet Prescription ORAL AB May 24, 2024
50MG

tablet Prescription ORAL AB May 24, 2024





22. MSN

Msn Laboratories Private Ltd has filed for 2 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Feb 9, 2023
10MG/ML

solution Prescription ORAL AA Dec 22, 2023


Manufacturing Plant Locations
New

Msn's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Msn as present at those locations.

Country City Firm Name
India
Yadadri Bhuvanagiri District MSN Organics Private Limited
Medak MSN LIFE SCIENCES PRIVATE LIMITED
Sangareddy MSN Laboratories Private Ltd.
Rangareddy District MSN Laboratories Private Limited
Isnapur MSN Laboratories Private Limited, Unit-II
Jinnaram, Sangareddy MSN Laboratories Private Limited - Formulations Division
Rangareddy District MSN Laboratories Private Limited (Formulations Division, Unit-II)
Sangareddy MSN Laboratories Private Limited, R&D Center
Sangareddy MSN Pharmachem Private Limited
Kamareddy MSN Life Sciences Private Limited
United States
Piscataway MSN PHARMACEUTICALS INC





23. MSN LABS PVT LTD

Msn Laboratories Private Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Msn Labs Pvt Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022





24. MYLAN PHARMS INC

Mylan Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Prescription ORAL AB Apr 28, 2016
50MG

tablet Prescription ORAL AB Apr 28, 2016
200MG

tablet Prescription ORAL AB Apr 28, 2016
100MG

tablet Prescription ORAL AB Apr 28, 2016





25. NOVITIUM PHARMA

Novitium Pharma Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Novitium Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG/ML

solution Prescription ORAL AA Aug 26, 2022


Manufacturing Plant Locations
New

Novitium Pharma's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Novitium Pharma as present at those locations.

Country City Firm Name
United States
East Windsor Novitium Pharma LLC





26. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Mar 17, 2022
50MG

tablet Prescription ORAL AB Mar 17, 2022
200MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022





27. SOMERSET THERAPS LLC

Somerset Therapeutics Llc has filed for 1 generic for Lacosamide. Given below are the details of the strengths of this generic introduced by Somerset Theraps Llc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Oct 9, 2024





28. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 17, 2022
150MG

tablet Prescription ORAL AB Mar 17, 2022
100MG

tablet Prescription ORAL AB Mar 17, 2022
50MG

tablet Prescription ORAL AB Mar 17, 2022


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Billerica Sun Pharmaceutical Industries, Inc.
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
India
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Ahmednagar Sun Pharmaceutical Industries Limited
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Vadodara Sun Pharmaceutical Industries Ltd
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Mohali Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Baruch Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Dadra Sun Pharmaceutical Industries Limited
Bharuch Sun Pharmaceutical Industries Ltd





29. UNICHEM

Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Unichem.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG

tablet Prescription ORAL AB Sep 4, 2024
200MG

tablet Prescription ORAL AB Sep 4, 2024
50MG

tablet Prescription ORAL AB Sep 4, 2024
100MG

tablet Prescription ORAL AB Sep 4, 2024


Manufacturing Plant Locations
New

Unichem's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Unichem as present at those locations.

Country City Firm Name
India
Pilerne Bardez Unichem Laboratories Limited
District Raigad Unichem Laboratories Ltd
Ghaziabad Unichem Laboratories Ltd.
Kolhapur Unichem Laboratories Limited
Mumbai Unichem Laboratories Limited
Pithampur Unichem Laboratories Limited
United States
East Brunswick Unichem Pharmaceuticals USA Inc.
Hasbrouck Heights Unichem Pharmaceuticals Usa Inc





30. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lacosamide. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG/20ML (10MG/ML)

solution Prescription INTRAVENOUS AP Jun 29, 2022
100MG

tablet Discontinued ORAL N/A Dec 15, 2023
50MG

tablet Discontinued ORAL N/A Dec 15, 2023
200MG

tablet Discontinued ORAL N/A Dec 15, 2023
150MG

tablet Discontinued ORAL N/A Dec 15, 2023